Early diagnosis of cataracts can significantly improve treatment outcomes. Nanoparticles can be engineered to target specific biomarkers associated with cataracts. These nanoparticles can be introduced into the eye, where they bind to the biomarkers and make them more visible using imaging techniques such as optical coherence tomography (OCT). This allows for earlier and more accurate detection.
